178 related articles for article (PubMed ID: 23621138)
1. Newly available and recent advances in drug-eluting stents.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Giannini F; Colombo A
Expert Rev Cardiovasc Ther; 2013 May; 11(5):555-66. PubMed ID: 23621138
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
[TBL] [Abstract][Full Text] [Related]
3. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
5. Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry.
Damman P; Abdel-Wahab M; Möllmann H; Richardt G; Chevalier B; Barragan P; Tijssen JG; Underwood P; Hamm CW
J Invasive Cardiol; 2012 Oct; 24(10):495-502. PubMed ID: 23043032
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
[TBL] [Abstract][Full Text] [Related]
7. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
Garg P; Mauri L
Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?
Harskamp RE; Park DW
Expert Rev Cardiovasc Ther; 2013 May; 11(5):541-53. PubMed ID: 23621137
[TBL] [Abstract][Full Text] [Related]
9. One-year outcomes of consecutive patients treated by Endeavor zotarolimus and Resolute zotarolimus stents: the impact of polymer coating in drug-eluting stent technology.
Talarico GP; Burzotta F; Trani C; Tommasino A; Niccoli G; Porto I; Leone AM; Mongiardo R; Schiavoni G; Crea F
Catheter Cardiovasc Interv; 2013 Feb; 81(2):268-73. PubMed ID: 22639426
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
Mahmoudi M; Delhaye C; Wakabayashi K; Ben-Dor I; Gonzalez MA; Maluenda G; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2011 Jun; 107(12):1757-62. PubMed ID: 21497782
[TBL] [Abstract][Full Text] [Related]
11. A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.
Han YL; Zhang L; Yang LX; Liu HL; Qu P; Li WM; Jiang TM; Li SM; Jing QM; Zhang QY; Xu B; Li Y; Gao RL
EuroIntervention; 2012 Nov; 8(7):815-22. PubMed ID: 23171802
[TBL] [Abstract][Full Text] [Related]
12. Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial.
Onuma Y; Miquel-Hebert K; Serruys PW;
EuroIntervention; 2013 Jan; 8(9):1047-51. PubMed ID: 23339811
[TBL] [Abstract][Full Text] [Related]
13. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
[TBL] [Abstract][Full Text] [Related]
14. Therapies targeting inflammation after stent implantation.
Okura H; Takagi T; Yoshida K
Curr Vasc Pharmacol; 2013 Jul; 11(4):399-406. PubMed ID: 23905635
[TBL] [Abstract][Full Text] [Related]
15. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
16. Current status of the Xience V® everolimus-eluting coronary stent system.
Claessen BE; Caixeta A; Henriques JP; Piek JJ
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1363-74. PubMed ID: 20936921
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of inflammatory biomarkers after stent implantation].
Niccoli G; Montone RA; Ferrante G; Minelli S; Crea F
G Ital Cardiol (Rome); 2011 Oct; 12(10):635-44. PubMed ID: 21947106
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
19. Progress in treatment by percutaneous coronary intervention: the stent of the future.
Muramatsu T; Onuma Y; Zhang YJ; Bourantas CV; Kharlamov A; Diletti R; Farooq V; Gogas BD; Garg S; García-García HM; Ozaki Y; Serruys PW
Rev Esp Cardiol (Engl Ed); 2013 Jun; 66(6):483-96. PubMed ID: 24776051
[TBL] [Abstract][Full Text] [Related]
20. [Role of bare metal stent in drug eluting stent era].
Takizawa K; Inoue N
Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
